NEWAMSTERDAM PHARMA COMPANY (NAMSW) Institutional Ownership and Insiders Activity

NEWAMSTERDAM PHARMA COMPANY (NAMSW) is widely held by institutional investors, with 1 tracked firm reporting positions valued at approximately $134.56M based on SEC Form 13F filings for the quarter ended March 31, 2026.

Viking Global Investors is the largest disclosed holder, reporting approximately $134.56M in NAMSW holdings in its latest filing.

Institutional ownership among tracked investors remains highly concentrated, with Viking Global Investors representing the majority of disclosed value.